Dr Agarwals Eye Hospital Ltd vs Syngene International Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Dr Agarwals Eye Hospital Ltd is ₹ 5035 as of 23 Oct 15:30 . The P/E Ratio of Dr Agarwals Eye Hospital Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 53.7 on March 2021 to 49.7 on March 2026 . This represents a CAGR of -1.28% over 6 years The Market Cap of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 21734 crore on March 2021 to ₹ 15724 crore on March 2026 . This represents a CAGR of -5.25% over 6 years The revenue of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Syngene International Ltd for the Jun '26 is ₹ 761.3 crore as compare to the Mar '26 revenue of ₹ 1058 crore. This represent the decline of -28.09% The ebitda of Dr Agarwals Eye Hospital Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Syngene International Ltd for the Jun '26 is ₹ 102.6 crore as compare to the Mar '26 ebitda of ₹ 319.6 crore. This represent the decline of -67.9% The net profit of Dr Agarwals Eye Hospital Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Syngene International Ltd changed from ₹ 75.7 crore to ₹ -9 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Dr Agarwals Eye Hospital Ltd changed from 5.85 % on March 2022 to 4.82 % on March 2026 . This represents a CAGR of -3.80% over 5 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 16.52 % on March 2026 . This represents a CAGR of 10.17% over 5 years .

About Dr Agarwals Eye Hospital Ltd

Founded in 1957, Dr. Agarwal's Eye Hospital Limited was incorporated on April 22, 1994.
The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu.
Company has been a pioneer and leader into the Indian Ophthalmology market in the eye care division.
It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others.
It has presence in Tamil Nadu, Kerala and Rajasthan states. The Company is primarily engaged in running, owning and managing eye care hospitals, opticals, pharmacies, etc. and related services.

About Syngene International Ltd

Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
Headquartered in India, the operations are driven by its highly qualified teams comprising 5,778scientists and its state-of-the-art facilities, spread over 3 million sq. ft.
The Company operate into 4 business divisions comprising of Discovery Services, Translational & Clinical Research, Dedicated Centers, and Contract Development and Manufacturing Services. Syngene International Limited was incorporated at Bangalore in 1993.
The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
The Company's health-related services extend across all major therapeutic areas and modalities.

FAQs for the comparison of Dr Agarwals Eye Hospital Ltd and Syngene International Ltd

Which company has a larger market capitalization, Dr Agarwals Eye Hospital Ltd or Syngene International Ltd?

Market cap of Dr Agarwals Eye Hospital Ltd is 2,433 Cr while Market cap of Syngene International Ltd is 14,810 Cr

What are the key factors driving the stock performance of Dr Agarwals Eye Hospital Ltd and Syngene International Ltd?

The stock performance of Dr Agarwals Eye Hospital Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Agarwals Eye Hospital Ltd and Syngene International Ltd?

As of October 25, 2026, the Dr Agarwals Eye Hospital Ltd stock price is INR ₹5035.8. On the other hand, Syngene International Ltd stock price is INR ₹366.9.

How do dividend payouts of Dr Agarwals Eye Hospital Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Dr Agarwals Eye Hospital Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.